ID   PLPP3_RAT               Reviewed;         312 AA.
AC   P97544;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   29-MAY-2024, entry version 130.
DE   RecName: Full=Phospholipid phosphatase 3 {ECO:0000305};
DE            EC=3.1.3.- {ECO:0000250|UniProtKB:O14495};
DE            EC=3.1.3.4 {ECO:0000250|UniProtKB:O14495};
DE   AltName: Full=Differentially expressed in rat intestine 42;
DE            Short=Dri42;
DE   AltName: Full=Lipid phosphate phosphohydrolase 3;
DE   AltName: Full=PAP2-beta;
DE   AltName: Full=Phosphatidate phosphohydrolase type 2b;
DE   AltName: Full=Phosphatidic acid phosphatase 2b;
DE            Short=PAP-2b;
DE            Short=PAP2b;
GN   Name=Plpp3 {ECO:0000312|RGD:620454}; Synonyms=Lpp3, Ppap2b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TOPOLOGY, AND
RP   GLYCOSYLATION.
RC   STRAIN=Wistar; TISSUE=Small intestine;
RX   PubMed=8939937; DOI=10.1074/jbc.271.47.29928;
RA   Barila D., Plateroti M., Nobili F., Muda A.O., Xie Y., Morimoto T.,
RA   Perozzi G.;
RT   "The Dri 42 gene, whose expression is upregulated during epithelial
RT   differentiation, encodes a novel ER resident transmembrane protein.";
RL   J. Biol. Chem. 271:29928-29936(1996).
RN   [2]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8055940; DOI=10.1111/j.1432-1033.1994.tb19043.x;
RA   Barila D., Murgia C., Nobili F., Gaetani S., Perozzi G.;
RT   "Subtractive hybridization cloning of novel genes differentially expressed
RT   during intestinal development.";
RL   Eur. J. Biochem. 223:701-709(1994).
RN   [3]
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11704545; DOI=10.1152/ajplung.2001.281.6.l1484;
RA   Nanjundan M., Possmayer F.;
RT   "Molecular cloning and expression of pulmonary lipid phosphate
RT   phosphohydrolases.";
RL   Am. J. Physiol. 281:L1484-L1493(2001).
CC   -!- FUNCTION: Magnesium-independent phospholipid phosphatase of the plasma
CC       membrane that catalyzes the dephosphorylation of a variety of
CC       glycerolipid and sphingolipid phosphate esters including
CC       phosphatidate/PA, lysophosphatidate/LPA, diacylglycerol
CC       pyrophosphate/DGPP, sphingosine 1-phosphate/S1P and ceramide 1-
CC       phosphate/C1P. Also acts on N-oleoyl ethanolamine phosphate/N-(9Z-
CC       octadecenoyl)-ethanolamine phosphate, a potential physiological
CC       compound. Has both an extracellular and an intracellular phosphatase
CC       activity, allowing the hydrolysis and the cellular uptake of these
CC       bioactive lipid mediators from the milieu, regulating signal
CC       transduction in different cellular processes. Through the
CC       dephosphorylation of extracellular sphingosine-1-phosphate and the
CC       regulation of its extra- and intracellular availability, plays a role
CC       in vascular homeostasis, regulating endothelial cell migration,
CC       adhesion, survival, proliferation and the production of pro-
CC       inflammatory cytokines (By similarity). By maintaining the appropriate
CC       levels of this lipid in the cerebellum, also ensure its proper
CC       development and function (By similarity). Through its intracellular
CC       lipid phosphatase activity may act in early compartments of the
CC       secretory pathway, regulating the formation of Golgi to endoplasmic
CC       reticulum retrograde transport carriers (By similarity).
CC       {ECO:0000250|UniProtKB:O14495, ECO:0000250|UniProtKB:Q99JY8}.
CC   -!- FUNCTION: Independently of this phosphatase activity may also function
CC       in the Wnt signaling pathway and the stabilization of beta-
CC       catenin/CTNNB1, thereby regulating cell proliferation, migration and
CC       differentiation in angiogenesis or yet in tumor growth. Also plays a
CC       role in integrin-mediated cell-cell adhesion in angiogenesis.
CC       {ECO:0000250|UniProtKB:Q99JY8}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphate + H2O = a 1,2-diacyl-sn-
CC         glycerol + phosphate; Xref=Rhea:RHEA:27429, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:43474, ChEBI:CHEBI:58608; EC=3.1.3.4;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27430;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphate + H2O = 1,2-
CC         dihexadecanoyl-sn-glycerol + phosphate; Xref=Rhea:RHEA:43236,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:72859,
CC         ChEBI:CHEBI:82929; Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43237;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + H2O = 1,2-
CC         di-(9Z-octadecenoyl)-sn-glycerol + phosphate; Xref=Rhea:RHEA:43244,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:52333,
CC         ChEBI:CHEBI:74546; Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43245;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + monoacyl-sn-glycero-3-phosphate = a monoacylglycerol +
CC         phosphate; Xref=Rhea:RHEA:46736, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:17408, ChEBI:CHEBI:43474, ChEBI:CHEBI:77589;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46737;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-sn-glycero-3-phosphate + H2O = (9Z-
CC         octadecenoyl)-glycerol + phosphate; Xref=Rhea:RHEA:50884,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:75937,
CC         ChEBI:CHEBI:84973; Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50885;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sphing-4-enine 1-phosphate = phosphate + sphing-4-enine;
CC         Xref=Rhea:RHEA:27518, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57756, ChEBI:CHEBI:60119;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:27519;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine 1-phosphate + H2O = an N-acylsphing-4-
CC         enine + phosphate; Xref=Rhea:RHEA:33743, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:52639, ChEBI:CHEBI:57674;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33744;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(octanoyl)-sphing-4-enine-1-phosphate = N-
CC         octanoylsphing-4-enine + phosphate; Xref=Rhea:RHEA:62040,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:45815,
CC         ChEBI:CHEBI:85376; Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62041;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-(9Z-octadecenoyl)-ethanolamine phosphate = N-(9Z-
CC         octadecenoyl) ethanolamine + phosphate; Xref=Rhea:RHEA:62160,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:71466,
CC         ChEBI:CHEBI:145465; Evidence={ECO:0000250|UniProtKB:O14495};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62161;
CC         Evidence={ECO:0000250|UniProtKB:O14495};
CC   -!- ACTIVITY REGULATION: Magnesium-independent phospholipid phosphatase.
CC       Insensitive to N-ethylmaleimide. Inhibited by sphingosine, zinc ions
CC       and modestly by propanolol. {ECO:0000250|UniProtKB:O14495}.
CC   -!- PATHWAY: Lipid metabolism; phospholipid metabolism.
CC       {ECO:0000250|UniProtKB:O14495}.
CC   -!- SUBUNIT: Forms functional homodimers and homooligomers that are not
CC       required for substrate recognition and catalytic activity. Can also
CC       form heterooligomers with other PLPP2 and PLPP3. Interacts with CTNND1;
CC       negatively regulates the PLPP3-mediated stabilization of beta-
CC       catenin/CTNNB1. {ECO:0000250|UniProtKB:O14495}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O14495};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:8939937}. Basolateral
CC       cell membrane {ECO:0000250|UniProtKB:O14495}; Multi-pass membrane
CC       protein {ECO:0000269|PubMed:8939937}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:8939937}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8939937}. Endoplasmic reticulum-Golgi intermediate
CC       compartment membrane {ECO:0000250|UniProtKB:O14495}; Multi-pass
CC       membrane protein {ECO:0000269|PubMed:8939937}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:O14495}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8939937}. Golgi apparatus, trans-Golgi network
CC       membrane {ECO:0000250|UniProtKB:O14495}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8939937}. Membrane raft
CC       {ECO:0000250|UniProtKB:O14495}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:8939937}. Note=Cycles between the endoplasmic
CC       reticulum and the Golgi. {ECO:0000250|UniProtKB:O14495}.
CC   -!- TISSUE SPECIFICITY: Detected in epithelial cells of intestinal mucosa,
CC       lung, liver and brain. {ECO:0000269|PubMed:11704545,
CC       ECO:0000269|PubMed:8055940}.
CC   -!- DEVELOPMENTAL STAGE: Expression is increased during epithelial
CC       differentiation in intestinal mucosa as well as in kidney, liver and
CC       lung. {ECO:0000269|PubMed:8055940}.
CC   -!- DOMAIN: The integrin-binding motif mediates the binding to integrin
CC       alpha-5/beta-1 (ITGA5:ITGB1) and integrin alpha-V/beta-3 (ITGAV:ITGB3)
CC       and is required for the function in integrin-mediated cell-cell
CC       adhesion. {ECO:0000250|UniProtKB:O14495}.
CC   -!- DOMAIN: The dityrosine basolateral targeting motif mediates
CC       localization to the basolateral membrane in polarized cells.
CC       {ECO:0000250|UniProtKB:O14495}.
CC   -!- PTM: N-glycosylated (PubMed:8939937). Contains high-mannose
CC       oligosaccharides (By similarity). {ECO:0000250|UniProtKB:O14495,
CC       ECO:0000269|PubMed:8939937}.
CC   -!- SIMILARITY: Belongs to the PA-phosphatase related phosphoesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y07783; CAA69106.1; -; mRNA.
DR   AlphaFoldDB; P97544; -.
DR   STRING; 10116.ENSRNOP00000011237; -.
DR   GlyCosmos; P97544; 1 site, No reported glycans.
DR   GlyGen; P97544; 1 site.
DR   iPTMnet; P97544; -.
DR   PhosphoSitePlus; P97544; -.
DR   PaxDb; 10116-ENSRNOP00000011237; -.
DR   UCSC; RGD:620454; rat.
DR   AGR; RGD:620454; -.
DR   RGD; 620454; Plpp3.
DR   eggNOG; KOG3030; Eukaryota.
DR   InParanoid; P97544; -.
DR   PhylomeDB; P97544; -.
DR   Reactome; R-RNO-9845614; Sphingolipid catabolism.
DR   UniPathway; UPA00085; -.
DR   PRO; PR:P97544; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:RGD.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; ISS:UniProtKB.
DR   GO; GO:0106235; F:ceramide-1-phosphate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0042577; F:lipid phosphatase activity; ISO:RGD.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0042392; F:sphingosine-1-phosphate phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0060020; P:Bergmann glial cell differentiation; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0007155; P:cell adhesion; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0033631; P:cell-cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; ISS:UniProtKB.
DR   GO; GO:0001702; P:gastrulation with mouth forming second; ISO:RGD.
DR   GO; GO:0034109; P:homotypic cell-cell adhesion; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:1902068; P:regulation of sphingolipid mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0006890; P:retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0006670; P:sphingosine metabolic process; ISS:UniProtKB.
DR   GO; GO:0042060; P:wound healing; ISO:RGD.
DR   CDD; cd03384; PAP2_wunen; 1.
DR   Gene3D; 1.20.144.10; Phosphatidic acid phosphatase type 2/haloperoxidase; 1.
DR   InterPro; IPR036938; P_Acid_Pase_2/haloperoxi_sf.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   InterPro; IPR043216; PA_PP_rel.
DR   PANTHER; PTHR10165; LIPID PHOSPHATE PHOSPHATASE; 1.
DR   PANTHER; PTHR10165:SF79; PHOSPHOLIPID PHOSPHATASE 3; 1.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; Acid phosphatase/Vanadium-dependent haloperoxidase; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Endoplasmic reticulum; Glycoprotein; Golgi apparatus;
KW   Hydrolase; Lipid metabolism; Membrane; Phosphoprotein; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..312
FT                   /note="Phospholipid phosphatase 3"
FT                   /id="PRO_0000220914"
FT   TOPO_DOM        1..33
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        34..54
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        55..85
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        86..106
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        107..123
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        124..144
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        145..194
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        195..215
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        216..226
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        227..244
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        245..258
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   TRANSMEM        259..279
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        280..312
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:8939937"
FT   REGION          149..157
FT                   /note="Phosphatase sequence motif I"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          197..200
FT                   /note="Phosphatase sequence motif II"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          245..256
FT                   /note="Phosphatase sequence motif III"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   REGION          276..312
FT                   /note="Mediates interaction with CTNND1"
FT                   /evidence="ECO:0000250|UniProtKB:O14495"
FT   MOTIF           109..110
FT                   /note="Dityrosine basolateral targeting motif"
FT                   /evidence="ECO:0000250|UniProtKB:O14495"
FT   MOTIF           183..185
FT                   /note="Integrin-binding motif"
FT                   /evidence="ECO:0000250|UniProtKB:O14495"
FT   ACT_SITE        200
FT                   /note="Proton donors"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   ACT_SITE        252
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   SITE            256
FT                   /note="Stabilizes the active site histidine for
FT                   nucleophilic attack"
FT                   /evidence="ECO:0000250|UniProtKB:O34349"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14495"
FT   CARBOHYD        171
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   312 AA;  35318 MW;  9B447FD321DB0419 CRC64;
     MQSYKYDKAI VPESKNGGSP ALNNNPRKGG SKRVLLICLD LFCLFMAALP FLIIETSTIK
     PYRRGFYCND ESIKYPLKVS ETINDAVLCA VGIVIAILRI ITGEFYRIYY LKEKSRSTIQ
     NPYVAALYKQ VGCFLFGCAI SQSFTDIAKV SIGRLRPHFL SVCDPDFSQI NCSEGYIQNY
     RCRGEDSKVQ EARKSFFSGH ASFSMFTMLY LVLYLQARFT WRGARLLRPL LQFTLLMMAF
     YTGLSRVSDY KHHPSDVLAG FAQGALVACC IVFFVSDLFK TKTTLSLPAP AIRREILSPV
     DIMDRSNHHN MV
//
